NCT07773337

Brief Summary

This study aims to evaluate the relationship between ovarian stromal stiffness measured by transvaginal shear wave elastography (SWE) and conventional hormonal and ultrasonographic parameters of ovarian reserve. Reproductive-aged female patients will be evaluated to determine whether tissue elasticity provided by SWE correlates with ovarian function markers such as anti-Müllerian hormone (AMH), antral follicle count (AFC), and ovarian volume.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Aug 2026Dec 2026

Study Start

First participant enrolled

August 1, 2026

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 19, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2026

Expected
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 20, 2026

Status Verified

August 1, 2026

Enrollment Period

4 months

First QC Date

August 14, 2026

Last Update Submit

August 18, 2026

Conditions

Keywords

Shear Wave ElastographyTransvaginal UltrasoundOvarian StromaAnti-Mullerian Hormone

Outcome Measures

Primary Outcomes (1)

  • Ovarian Stromal Elasticity Value

    Measurement of ovarian stromal tissue stiffness/elasticity using transvaginal shear wave elastography, expressed in kilopascals (kPa) or velocity (m/s).

    At the time of baseline ultrasound examination(Day 1)

Secondary Outcomes (6)

  • Serum Anti- Mullerian Hormone (AMH)

    At baseline (Day 1)

  • Antral Follicle Count (AFC)

    At baseline ultasound examination (Day 1)

  • Ovarian Volume

    At baseline ultrasound examination(Day 1)

  • Serum Follicle-Stimulating Hormone

    at baseline (day 1)

  • Serum Luteinizing Hormone (LH)

    at baseline (day 1)

  • +1 more secondary outcomes

Study Arms (1)

Ovarian Function Assessment Group

OTHER

Female Patients of Reproductive Age

Diagnostic Test: Transvaginal Shear Wave Elastography

Interventions

Measurement of ovarian stromal elasticity using transvaginal shear wave elastography alongside standard ultrasound evaluation of antral follicle count and ovarian volume

Ovarian Function Assessment Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Female patients aged 18 to 45 years.
  • Regular menstrual cycles (21-35 days) or irregular menstruel cycles (oligo-anovaltion)
  • Normal pelvic anatomy on baseline ultrasound evaluation.
  • Written informed consent to participate in the study.

You may not qualify if:

  • History of prior ovarian or adnexal surgery.
  • History of pelvic radiotherapy or chemotherapy.
  • Presence of structural pelvic/ovarian pathology (e.g., endometrioma, ovarian cyst, dermoid cyst, active pelvic inflammatory disease).
  • Use of hormonal contraceptives, ovulation induction agents, or hormone therapy within the last 3 months.
  • Pregnancy or current lactation.
  • Severe obesity or technical limitations preventing adequate transvaginal ultrasound and elastography imaging

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences Gazi Yaşargil Training and Research Hospital, Department of Obstetrics and Gynaecology

Diyarbakır, 21090, Turkey (Türkiye)

Location

Related Publications (4)

  • Zorlu U, Yilmazer-Zorlu SN, Yalcin HR. Can shear wave elastography be used as a diagnostic marker in polycystic ovary syndrome? Int J Gynaecol Obstet. 2026 Feb;172(2):1202-1210. doi: 10.1002/ijgo.70471. Epub 2025 Aug 14.

    PMID: 40810622BACKGROUND
  • Mumusoglu S, Yang Q, Kawamura K, Chang M C, Liu K, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles: a quarter-century update. Reprod Biomed Online. 2025 Nov;51(5):105108. doi: 10.1016/j.rbmo.2025.105108. Epub 2025 Jun 18.

    PMID: 41067165BACKGROUND
  • Zaniker EJ, Zhang M, Hughes L, La Follette L, Atazhanova T, Trofimchuk A, Babayev E, Duncan FE. Shear wave elastography to assess stiffness of the human ovary and other reproductive tissues across the reproductive lifespan in health and diseasedagger. Biol Reprod. 2024 Jun 12;110(6):1100-1114. doi: 10.1093/biolre/ioae050.

    PMID: 38609185BACKGROUND
  • Yildirim M, Duran Kaymak S, Cayonu Kahraman N, Savran Ucok B, Engin-Ustun Y. Assessment of Ovarian Stiffness in Women With Polycystic Ovary Syndrome: A Tertiary Center Shear Wave Elastography Study. J Ultrasound Med. 2025 Oct;44(10):1797-1806. doi: 10.1002/jum.16731. Epub 2025 Jun 2.

    PMID: 40455435BACKGROUND

MeSH Terms

Conditions

InfertilityAnovulation

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital DiseasesOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsGonadal DisordersEndocrine System Diseases

Study Officials

  • Serap M. ÖZÇELİK OTCU, MD, AssocProf.

    University of Health Sciences Gazi Yasargil Training and Research Hospital, Dept. of OB/GYN

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department(Department of Obstetrics and Gynaecology)

Study Record Dates

First Submitted

August 14, 2026

First Posted

August 19, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

November 15, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 20, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations